<p><h1>Antisense & RNAi Therapeutics Market Growth, Market Trends, COVID-19 Impact, and Forecasts for period from 2024 - 2031</h1></p><p><strong>Antisense & RNAi Therapeutics Market Analysis and Latest Trends</strong></p>
<p><p>Antisense & RNAi Therapeutics involve the use of nucleic acid molecules to target specific genes and inhibit their expression, thereby treating various diseases at the genetic level. This emerging field of therapeutics has shown great promise in treating conditions such as cancer, genetic disorders, and viral infections.</p><p>The Antisense & RNAi Therapeutics Market is witnessing rapid growth, with an expected CAGR of 13.3% during the forecast period. This growth is driven by factors such as increasing prevalence of genetic disorders, rising demand for personalized medicine, and advancements in biotechnology and genomics. Additionally, the development of novel delivery systems and the approval of new antisense and RNAi therapeutics by regulatory authorities are further propelling market growth.</p><p>Moreover, the market is witnessing a shift towards the development of RNA-based therapeutics, as they offer greater specificity and lower toxicity compared to traditional small molecule drugs. Companies are investing heavily in research and development to bring innovative antisense and RNAi therapies to the market. Overall, the Antisense & RNAi Therapeutics Market is poised for significant expansion in the coming years.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1013376">https://www.reliableresearchreports.com/enquiry/request-sample/1013376</a></p>
<p>&nbsp;</p>
<p><strong>Antisense & RNAi Therapeutics Major Market Players</strong></p>
<p><p>The global Antisense & RNAi Therapeutics market is highly competitive with key players such as Glaxo Smith Kline, Sanofi Aventis / Genzyme, Isis Pharmaceuticals/ Ionis Pharmaceuticals, Arbutus Biopharma Ltd., Silence Therapeutics, Bio-Path Holdings Inc., Calando Pharmaceuticals, ICo Therapeutics, Quark Pharmaceuticals, Rexhan Pharmaceuticals, Biomarin/Prosensa, Regulus Therapeutics, Rxi Pharmaceuticals, Silenseed, Dicerna Pharmaceuticals, and Sirnaomics Inc.</p><p>Among these players, Ionis Pharmaceuticals is a prominent company known for its innovative RNA-targeted drug discovery platform. The company has shown steady growth in recent years, with a strong pipeline of RNA-targeted therapeutics for various diseases. Ionis Pharmaceuticals had reported sales revenue of approximately $737 million in 2020.</p><p>Another key player in the market is Dicerna Pharmaceuticals, known for its GalXC™ RNAi technology platform. The company has focused on developing therapies for liver diseases, metabolic disorders, and cancer. Dicerna Pharmaceuticals saw a significant increase in sales revenue, reaching approximately $71 million in 2020.</p><p>As the demand for Antisense & RNAi therapeutics continues to grow, companies like Ionis Pharmaceuticals and Dicerna Pharmaceuticals are expected to expand their market presence and revenue. The global market size for Antisense & RNAi therapeutics is projected to reach $1.5 billion by 2027, driven by the increasing prevalence of genetic disorders, cancer, and infectious diseases. These key players are likely to capture a significant portion of this market growth through their innovative technologies and extensive pipeline of therapeutics.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Antisense & RNAi Therapeutics Manufacturers?</strong></p>
<p><p>The Antisense & RNAi Therapeutics market has been experiencing significant growth in recent years, fueled by advancements in genetic research and the development of innovative therapies. The market is expected to continue to expand at a steady pace, driven by the increasing prevalence of genetic disorders and the growing demand for personalized medicine. The future outlook for the market is promising, with ongoing research and development efforts aimed at bringing new and improved therapies to market. Additionally, collaborations between pharmaceutical companies and research institutions are expected to further drive growth in the Antisense & RNAi Therapeutics market.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1013376">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1013376</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Antisense & RNAi Therapeutics Market Analysis by types is segmented into:</strong></p>
<p><ul><li>RNA Interference</li><li>SiRNA</li><li>MiRNA</li><li>Antisense RNA</li></ul></p>
<p><p>Antisense & RNAi therapeutics market is classified into different types based on their mechanism of action. RNA interference (RNAi) involves the use of small interfering RNAs (siRNA) or microRNAs (miRNA) to target and degrade specific messenger RNA molecules, thereby preventing protein translation. Antisense RNA therapy, on the other hand, involves the use of synthetic RNA molecules that bind to complementary mRNA sequences to inhibit protein production. These different approaches provide effective means of targeting specific genes and treating various diseases.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1013376">https://www.reliableresearchreports.com/purchase/1013376</a></p>
<p>&nbsp;</p>
<p><strong>The Antisense & RNAi Therapeutics Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Oncology</li><li>Cardiovascular</li><li>Renal</li><li>Neurodegenerative</li><li>Respiratory</li><li>Genetic</li><li>Infectious Diseases</li></ul></p>
<p><p>Antisense & RNAi therapeutics have broad applications in various medical fields such as oncology, cardiovascular, renal, neurodegenerative, respiratory, genetic, and infectious diseases. These therapies work by targeting specific genes involved in diseases and regulating their expression. In oncology, they can inhibit tumor growth, while in cardiovascular diseases, they can target factors leading to heart conditions. They also show promise in addressing conditions such as kidney disease, neurodegenerative disorders, respiratory illnesses, genetic disorders, and infectious diseases.</p></p>
<p><a href="https://www.reliableresearchreports.com/antisense-and-rnai-therapeutics-r1013376">&nbsp;https://www.reliableresearchreports.com/antisense-and-rnai-therapeutics-r1013376</a></p>
<p><strong>In terms of Region, the Antisense & RNAi Therapeutics Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The Antisense & RNAi Therapeutics market is expected to witness significant growth in North America (NA), Europe, Asia-Pacific (APAC), USA, and China. Among these regions, North America and Europe are projected to dominate the market with a market share of 35% and 30%, respectively. The USA is anticipated to hold a market share of 20%, followed by China at 10%. The APAC region is also expected to see substantial growth, with a market share of 15%.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1013376">https://www.reliableresearchreports.com/purchase/1013376</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1013376">https://www.reliableresearchreports.com/enquiry/request-sample/1013376</a></p>
<p><strong></strong></p>
<p><p><a href="https://github.com/AbigaleHuel/Market-Research-Report-List-1/blob/main/5686462173239.md">CO2レーザーカッティングヘッド</a></p><p><a href="https://github.com/AdellaPrice2023/Market-Research-Report-List-2/blob/main/4042819173238.md">ウォーターナイフ切断機</a></p><p><a href="https://github.com/nigngrjl95/Market-Research-Report-List-1/blob/main/dna-extraction-reagent-market.md">DNA Extraction Reagent Market</a></p><p><a href="https://github.com/sarohimweaach77/Market-Research-Report-List-1/blob/main/cryoprobe-market.md">Cryoprobe Market</a></p></p>